Alice Trickett
Research Assistant
Functional Genomics of Extreme Immune Responses
Inappropriate immune responses underpin various diseases and auto-inflammatory states including sepsis. Our current research goal is to define and characterise extreme immune response phenotypes which should resolve functional alleles, mechanisms of gene regulation and pathophysiology. Characterising individual extreme responders could contribute to better understanding patient specific responses to treatment and thus offer opportunities for personalised therapy. Furthermore, findings could provide insight into the critical mechanisms behind individual patient responses in sepsis including epigenetics and immune-metabolic adaption. Identifying key genes, networks and pathways for therapeutic intervention is particularly important given the high failure rate of drug trials, with genetic evidence enhancing predictions of drug efficacy.
I have worked as an RA in Julian Knight's group for the past 5 years with my main laboratory work involving cell culture and handling of patient blood samples.
Recent publications
-
Epigenomic analysis reveals a dynamic and context-specific macrophage enhancer landscape associated with innate immune activation and tolerance
Journal article
Zhang P. et al, (2022), Genome Biology, 23
-
Identification of deleterious neutrophil states and altered granulopoiesis in sepsis
Preprint
Kwok AJ. et al, (2022)
-
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Journal article
Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58
-
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
Journal article
Townsend A. et al, (2021), Nature Communications, 12
-
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Working paper
Ahern DJ. et al, (2021)
-
ABCG2 requires a single aromatic amino acid to “clamp” substrates and inhibitors into the binding pocket
Journal article
Gose T. et al, (2020), The FASEB Journal, 34, 4890 - 4903
-
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
Journal article
Townsend A. et al, (2020)